Cyclopropylacetylene is used as a key intermediate in the synthesis of the anti-HIV drug efavirenz, a non-nucleoside reverse transcriptase inhibitor employed in highly active antiretroviral therapy (HAART) for the treatment of HIV Type I; it is also utilized as a building block in organic and medicinal chemistry for the synthesis of pharmaceuticals and bioactive molecules; additionally, it is employed in various organic reactions, including the synthesis of BACE1 inhibitors for the treatment of Alzheimer’s disease, cycloaddition reactions, and the preparation of fluoromethyl sydnones.